Surrozen Aktie - SRZN

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

11,51

Gebot

11,00

Fragen

12,45

Volumen

11,51 Tagesbereich 11,51

5,9999 52-Wochen-Bereich 18,17

Marktkapitalisierung

37,405M

Handelsende

11,71

Handelsbeginn

11,51

Letzte Trade

11.51

Letzter Handelszeitpunkt

14:30:00

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

33.241

Ausgegebene Aktien

3.249.798

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,88

Gewinn pro Aktie (EPS)

-13,24

Erlöse

Nettogewinn

-43,04M

Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.surrozen.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Surrozen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker SRZN. The last closing price for Surrozen was US$11,71. Over the last year, Surrozen shares have traded in a share price range of US$ 5,9999 to US$ 18,17.

Surrozen currently has 3.249.798 shares in issue. The market capitalisation of Surrozen is US$38,06 million. Surrozen has a price to earnings ratio (PE ratio) of -0.88.

Surrozen to Present at Upcoming Healthcare Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”...

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Substantial enrollment progress in Phase 1b trial of SZN-043 in severe alcohol-associated hepatitis patients...

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”...

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Boehringer is advancing the development of SZN-413 to prepare it for potential future clinical testing SZN-413...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Enrollment ongoing in SZN-043 Phase 1b trial in patients with Severe Alcoholic Hepatitis Presented...

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment...

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in...

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

SZN-043 is a novel hepatocyte-specific R-spondin mimetic bispecific fusion protein targeting ASGR1Anticipate...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.29	2.58467023173	11.22	12	10.31	6780	11.44986388	CS
4	1.46	14.5273631841	10.05	12.5499	9.5	14531	11.14475177	CS
12	1.66	16.8527918782	9.85	18.17	9.5	33241	12.66944959	CS
26	3.265	39.5997574287	8.245	18.17	7.5	31394	11.48065495	CS
52	-1.98	-14.6775389177	13.49	18.17	5.9999	21907	11.05237798	CS
156	-32.14	-73.6311569301	43.65	59.5785	4.5	142892	11.52158364	CS
260	-131.74	-91.965095986	143.25	210	4.5	143255	30.44108299	CS

SRZN - Frequently Asked Questions (FAQ)

What is the current Surrozen share price?

The current share price of Surrozen is US$ 11,51

How many Surrozen shares are in issue?

Surrozen has 3.249.798 shares in issue

What is the market cap of Surrozen?

The market capitalisation of Surrozen is USD 38,06M

What is the 1 year trading range for Surrozen share price?

Surrozen has traded in the range of US$ 5,9999 to US$ 18,17 during the past year

What is the PE ratio of Surrozen?

The price to earnings ratio of Surrozen is -0,88

What is the reporting currency for Surrozen?

Surrozen reports financial results in USD

What is the latest annual profit for Surrozen?

The latest annual profit of Surrozen is USD -43,04M

What is the registered address of Surrozen?

The registered address for Surrozen is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Surrozen website address?

The website address for Surrozen is www.surrozen.com

Which industry sector does Surrozen operate in?

Surrozen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
SYRSSyros Pharmaceuticals Inc	US$ 0,202 (120,52%)	195,94M
TSVT2seventy bio Inc	US$ 4,925 (75,89%)	10,23M
AWHAspira Womans Health Inc	US$ 0,3165 (59,85%)	127,15M
CUTRCutera Inc	US$ 0,1992 (55,02%)	81,05M
ONDSOndas Holdings Inc	US$ 1,078 (48,28%)	41,55M
ARVNArvinas Inc	US$ 9,74 (-44,53%)	2,79M
EWCZEuropean Wax Center Inc	US$ 3,00 (-41,29%)	25,8k
LZMHLZ Technology Holdings Ltd	US$ 10,65 (-31,99%)	55,18k
SPGCSacks Parente Golf Inc	US$ 0,1101 (-31,23%)	15,74M
ELTKEltek Ltd	US$ 8,54 (-21,69%)	50,82k
SYRSSyros Pharmaceuticals Inc	US$ 0,20135 (119,81%)	188,92M
AWHAspira Womans Health Inc	US$ 0,3197 (61,46%)	125,17M
CUTRCutera Inc	US$ 0,199 (54,86%)	79,91M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7,96 (7,86%)	62,37M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,037 (10,45%)	59,82M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Surrozen Inc (SRZN)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Surrozen Inc

SRZN Neueste Nachrichten

Surrozen to Present at Upcoming Healthcare Investor Conferences

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

Surrozen to Present at Upcoming Healthcare Investor Conferences

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

SRZN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Surrozen Inc (SRZN) Börsenkurse

Surrozen Inc (SRZN)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Surrozen Inc

SRZN Neueste Nachrichten

Surrozen to Present at Upcoming Healthcare Investor Conferences

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis

Surrozen to Present at Upcoming Healthcare Investor Conferences

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling

SRZN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen